[go: up one dir, main page]

CN114808179B - Composite material with controllable relaxation time and preparation method and application thereof - Google Patents

Composite material with controllable relaxation time and preparation method and application thereof Download PDF

Info

Publication number
CN114808179B
CN114808179B CN202210324742.4A CN202210324742A CN114808179B CN 114808179 B CN114808179 B CN 114808179B CN 202210324742 A CN202210324742 A CN 202210324742A CN 114808179 B CN114808179 B CN 114808179B
Authority
CN
China
Prior art keywords
relaxation time
acid
chain fatty
long
composite material
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202210324742.4A
Other languages
Chinese (zh)
Other versions
CN114808179A (en
Inventor
王林格
贾毅凡
于倩倩
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
South China University of Technology SCUT
Original Assignee
South China University of Technology SCUT
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by South China University of Technology SCUT filed Critical South China University of Technology SCUT
Priority to CN202210324742.4A priority Critical patent/CN114808179B/en
Publication of CN114808179A publication Critical patent/CN114808179A/en
Application granted granted Critical
Publication of CN114808179B publication Critical patent/CN114808179B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • DTEXTILES; PAPER
    • D01NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
    • D01FCHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
    • D01F6/00Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof
    • D01F6/88Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof from mixtures of polycondensation products as major constituent with other polymers or low-molecular-weight compounds
    • D01F6/92Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof from mixtures of polycondensation products as major constituent with other polymers or low-molecular-weight compounds of polyesters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/06Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10Organic compounds
    • A61K49/12Macromolecular compounds
    • A61K49/126Linear polymers, e.g. dextran, inulin, PEG
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/06Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10Organic compounds
    • A61K49/14Peptides, e.g. proteins
    • DTEXTILES; PAPER
    • D01NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
    • D01DMECHANICAL METHODS OR APPARATUS IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS
    • D01D5/00Formation of filaments, threads, or the like
    • D01D5/0007Electro-spinning
    • D01D5/0015Electro-spinning characterised by the initial state of the material
    • D01D5/003Electro-spinning characterised by the initial state of the material the material being a polymer solution or dispersion
    • DTEXTILES; PAPER
    • D01NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
    • D01DMECHANICAL METHODS OR APPARATUS IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS
    • D01D5/00Formation of filaments, threads, or the like
    • D01D5/0007Electro-spinning
    • D01D5/0061Electro-spinning characterised by the electro-spinning apparatus
    • DTEXTILES; PAPER
    • D01NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
    • D01DMECHANICAL METHODS OR APPARATUS IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS
    • D01D5/00Formation of filaments, threads, or the like
    • D01D5/0007Electro-spinning
    • D01D5/0061Electro-spinning characterised by the electro-spinning apparatus
    • D01D5/0092Electro-spinning characterised by the electro-spinning apparatus characterised by the electrical field, e.g. combined with a magnetic fields, using biased or alternating fields
    • DTEXTILES; PAPER
    • D01NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
    • D01FCHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
    • D01F1/00General methods for the manufacture of artificial filaments or the like
    • D01F1/02Addition of substances to the spinning solution or to the melt
    • D01F1/10Other agents for modifying properties
    • DTEXTILES; PAPER
    • D01NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
    • D01FCHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
    • D01F2/00Monocomponent artificial filaments or the like of cellulose or cellulose derivatives; Manufacture thereof
    • D01F2/06Monocomponent artificial filaments or the like of cellulose or cellulose derivatives; Manufacture thereof from viscose
    • D01F2/08Composition of the spinning solution or the bath
    • D01F2/10Addition to the spinning solution or spinning bath of substances which exert their effect equally well in either
    • DTEXTILES; PAPER
    • D01NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
    • D01FCHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
    • D01F2/00Monocomponent artificial filaments or the like of cellulose or cellulose derivatives; Manufacture thereof
    • D01F2/24Monocomponent artificial filaments or the like of cellulose or cellulose derivatives; Manufacture thereof from cellulose derivatives
    • D01F2/28Monocomponent artificial filaments or the like of cellulose or cellulose derivatives; Manufacture thereof from cellulose derivatives from organic cellulose esters or ethers, e.g. cellulose acetate
    • DTEXTILES; PAPER
    • D01NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
    • D01FCHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
    • D01F6/00Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof
    • D01F6/44Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof from mixtures of polymers obtained by reactions only involving carbon-to-carbon unsaturated bonds as major constituent with other polymers or low-molecular-weight compounds
    • D01F6/50Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof from mixtures of polymers obtained by reactions only involving carbon-to-carbon unsaturated bonds as major constituent with other polymers or low-molecular-weight compounds of polyalcohols, polyacetals or polyketals
    • DTEXTILES; PAPER
    • D01NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
    • D01FCHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
    • D01F6/00Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof
    • D01F6/44Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof from mixtures of polymers obtained by reactions only involving carbon-to-carbon unsaturated bonds as major constituent with other polymers or low-molecular-weight compounds
    • D01F6/56Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof from mixtures of polymers obtained by reactions only involving carbon-to-carbon unsaturated bonds as major constituent with other polymers or low-molecular-weight compounds of polymers of cyclic compounds with one carbon-to-carbon double bond in the side chain
    • DTEXTILES; PAPER
    • D04BRAIDING; LACE-MAKING; KNITTING; TRIMMINGS; NON-WOVEN FABRICS
    • D04HMAKING TEXTILE FABRICS, e.g. FROM FIBRES OR FILAMENTARY MATERIAL; FABRICS MADE BY SUCH PROCESSES OR APPARATUS, e.g. FELTS, NON-WOVEN FABRICS; COTTON-WOOL; WADDING ; NON-WOVEN FABRICS FROM STAPLE FIBRES, FILAMENTS OR YARNS, BONDED WITH AT LEAST ONE WEB-LIKE MATERIAL DURING THEIR CONSOLIDATION
    • D04H1/00Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres
    • D04H1/70Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres characterised by the method of forming fleeces or layers, e.g. reorientation of fibres
    • D04H1/72Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres characterised by the method of forming fleeces or layers, e.g. reorientation of fibres the fibres being randomly arranged
    • D04H1/728Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres characterised by the method of forming fleeces or layers, e.g. reorientation of fibres the fibres being randomly arranged by electro-spinning
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P70/00Climate change mitigation technologies in the production process for final industrial or consumer products
    • Y02P70/50Manufacturing or production processes characterised by the final manufactured product
    • Y02P70/62Manufacturing or production processes characterised by the final manufactured product related technologies for production or treatment of textile or flexible materials or products thereof, including footwear

Landscapes

  • Engineering & Computer Science (AREA)
  • Textile Engineering (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mechanical Engineering (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Manufacturing & Machinery (AREA)
  • Artificial Filaments (AREA)

Abstract

本发明属于功能纤维材料领域,公开了一种可控弛豫时间的复合材料及其制备方法和应用。通过静电纺丝技术将有机含氢分子造影剂负载在高分子材料的孔洞中,使得有机含氢分子造影剂受限,从而引起其氢原子弛豫时间的降低。在不添加额外物质的情况下,仅改变负载高分子材料的结构即可实现对有机含氢分子造影剂弛豫时间的调控。相较于已公开技术具有生物安全性高、无毒、无过敏、适用范围广的特点。可以引用于高分子MRI造影剂、标准弛豫时间样品、标准MRI信号强度的材料的制备。

Figure 202210324742

The invention belongs to the field of functional fiber materials, and discloses a composite material with controllable relaxation time, a preparation method and application thereof. The organic hydrogen-containing molecular contrast agent is loaded in the pores of the polymer material by electrospinning technology, so that the organic hydrogen-containing molecular contrast agent is confined, thereby reducing the relaxation time of its hydrogen atoms. Without adding additional substances, the relaxation time of the organic hydrogen-containing molecular contrast agent can be adjusted only by changing the structure of the loaded polymer material. Compared with the disclosed technology, it has the characteristics of high biological safety, non-toxicity, non-allergy and wide application range. It can be used in the preparation of polymeric MRI contrast agents, standard relaxation time samples, and standard MRI signal intensity materials.

Figure 202210324742

Description

一种可控弛豫时间的复合材料及其制备方法和应用A composite material with controllable relaxation time and its preparation method and application

技术领域technical field

本发明属于功能纤维材料领域,更具体地,涉及一种可控弛豫时间的复合材料及其制备方法与应用。The invention belongs to the field of functional fiber materials, and more specifically relates to a composite material with controllable relaxation time and its preparation method and application.

背景技术Background technique

磁共振成像技术(MRI)Magnetic Resonance Imaging (MRI)

磁共振是指原子核在一定条件下与外加磁场共振的物理现象。磁共振成像技术(MRI)的基本工作原理是将被测物体置于特殊的磁场中,用无线电射频脉冲激发物体内的氢原子核,引起氢原子核共振,并吸收能量。在停止射频脉冲后,氢原子核将吸收的能量释放出来,按特定频率发出无线电信号。这一无线电信号被MRI设备的接收器收集,经计算机处理获得图像。目前人用MRI设备所采集的信号主要都自于氢原子(见杨正汉等人著《磁共振成像技术指南》,人民军医出版社,2010:P18-19)。Magnetic resonance refers to the physical phenomenon that atomic nuclei resonate with an external magnetic field under certain conditions. The basic working principle of magnetic resonance imaging (MRI) is to place the measured object in a special magnetic field, and use radio frequency pulses to excite the hydrogen nuclei in the object, causing the hydrogen nuclei to resonate and absorb energy. After stopping the radio frequency pulses, the hydrogen nuclei release the absorbed energy, emitting a radio signal at a specific frequency. This radio signal is picked up by a receiver in the MRI machine and processed by a computer to create an image. At present, the signals collected by human MRI equipment are mainly from hydrogen atoms (see Yang Zhenghan et al. "Magnetic Resonance Imaging Technology Guide", People's Military Medical Press, 2010: P18-19).

MRI的信号强度与弛豫时间MRI signal intensity and relaxation time

不同环境下的氢原子(如被键合、处于孔道中、高温等),在被射频脉冲激发后,回归基态时释放能量的速度有快有慢。这个能量释放过程被称为弛豫,弛豫存在两个独立的过程,被称为T1与T2弛豫(或横向、纵向弛豫),两个弛豫过程发生的所需要消耗的时间被称为T1与T2弛豫时间。Hydrogen atoms in different environments (such as being bonded, in pores, high temperature, etc.), after being excited by radio frequency pulses, release energy at different speeds when returning to the ground state. This energy release process is called relaxation. There are two independent processes of relaxation, which are called T1 and T2 relaxation (or transverse and longitudinal relaxation). The time required for the two relaxation processes to occur is called are T1 and T2 relaxation times.

MRI有多种扫描序列用于获得信号,其中最常用的序列有T1WI(T1加权成像)、T2WI(T2加权成像)、PDWI(质子加权成像)、DWI(扩散加权成像)等,而以上这些常用扫描序列所得到的图像的信号强度均受到氢原子T1与T2弛豫时间的影响,也就是说不同弛豫时间的氢原子在MRI图像上的信号强度是不同的(见Ray H.Hashemi et al.MRI:TheBasics.Lippincott Williams&Wilkins,2012,p54-55)。MRI has a variety of scanning sequences used to obtain signals, the most commonly used sequences are T1WI (T1-weighted imaging), T2WI (T2-weighted imaging), PDWI (proton-weighted imaging), DWI (diffusion-weighted imaging), etc., and these commonly used The signal intensity of the image obtained by the scanning sequence is affected by the relaxation time of hydrogen atoms T1 and T2, that is to say, the signal intensity of hydrogen atoms with different relaxation times on the MRI image is different (see Ray H.Hashemi et al . MRI: The Basics. Lippincott Williams & Wilkins, 2012, p54-55).

高分子材料无法产生足够的MRI信号Polymer materials cannot generate sufficient MRI signal

高分子材料已被广泛用于制造医疗器械,然而高分子材料所含有的氢原子,其T2弛豫时间过短,在数十毫秒甚至数十纳秒的范围内。MRI由于本身设备的限制难以探测如此短弛豫时间的氢原子,从而使得高分子在人体内无法被MRI成像。这一现象在Yuan等人的研究(Yuan D C et al.Journal of Biomedical Materials Research Part B-AppliedBiomaterials,2019,107(7):2305-2316)中就可以看到,他们将聚合物(聚丁二酸丁二酯-对苯二甲酸丁二酯)纤维作为人造椎间盘替代髓核,但其在MRI下完全无信号。这一问题导致医生难以通过MRI获知植入的高分子材料在患者体内的信息,对治疗带来障碍。Polymer materials have been widely used in the manufacture of medical devices, but the T2 relaxation time of hydrogen atoms contained in polymer materials is too short, in the range of tens of milliseconds or even tens of nanoseconds. MRI is difficult to detect hydrogen atoms with such a short relaxation time due to the limitations of its own equipment, so that polymers in the human body cannot be imaged by MRI. This phenomenon can be seen in the research of Yuan et al. (Yuan D C et al. Journal of Biomedical Materials Research Part B-Applied Biomaterials, 2019, 107(7): 2305-2316). Butylene terephthalate-butylene terephthalate) fibers were used as artificial discs to replace the nucleus pulposus, but they were completely signalless under MRI. This problem makes it difficult for doctors to obtain the information of implanted polymer materials in the patient's body through MRI, which brings obstacles to treatment.

已公开造影技术及其缺陷Published imaging techniques and their drawbacks

MRI造影技术种类多样,其中一种常用的方法是使用造影剂。MRI造影剂按照提供信号的分子类型,可以分类两大类:(1)水分子,通过具有磁性的造影剂缩短水分子的T1与T2弛豫时间,从而改变MRI信号强度。使得造影剂所在位置的水分子信号强度发生显著变化,从而为该位置提供足够的信号对比度。这一类型的造影剂最为常见;(2)油脂、植物油、蔗糖聚酯等有机含氢分子(见杨正汉等人著《磁共振成像技术指南》,人民军医出版社,2010:P390),这些分子具有一个统一的特点,它们的分子组成中总是有长链脂肪基团,这是因为长链脂肪中的氢是其MRI信号的来源。这类分子中的氢天然就可以作为高MRI信号强度的来源。There are many types of MRI contrast techniques, one of which is the use of contrast agents. MRI contrast agents can be classified into two categories according to the type of molecules that provide signals: (1) Water molecules, which shorten the T1 and T2 relaxation times of water molecules through magnetic contrast agents, thereby changing the MRI signal intensity. The signal intensity of the water molecules at the position where the contrast agent is located changes significantly, thereby providing sufficient signal contrast for the position. This type of contrast agent is the most common; (2) organic hydrogen-containing molecules such as fats, vegetable oils, and sucrose polyesters (see "Guidelines for Magnetic Resonance Imaging Techniques" by Yang Zhenghan et al., People's Military Medical Press, 2010: P390), these molecules They have a unified feature that they always have long-chain fatty groups in their molecular composition, because the hydrogen in long-chain fat is the source of their MRI signals. The hydrogen in these molecules is a natural source of high MRI signal intensity.

对于第(2)类有机含氢分子造影剂而言,由于弛豫时间是物质本身的性质,有机含氢分子在仅自身存在的情况下,其弛豫时间(即MRI信号强度)是不可调的,仅能表现为单一数值。然而对于应用在不同人体部位的高分子植入医疗器械,其需要造影的MRI信号强度是不同的,仅能表现为单一信号强度的有机含氢分子造影剂,在面对MRI信号强度随使用环境需要变化的情况时,有机含氢分子的性能就不足以满足可变信号强度的需求了。For the (2) class of organic hydrogen-containing molecular contrast agents, since the relaxation time is the property of the substance itself, the relaxation time (ie, the MRI signal intensity) of the organic hydrogen-containing molecule is not adjustable when it only exists by itself. , can only be expressed as a single value. However, for polymer implanted medical devices used in different parts of the human body, the MRI signal intensity required for imaging is different, and the organic hydrogen-containing molecular contrast agent that can only be expressed as a single signal intensity, in the face of the MRI signal intensity varies with the use environment. When varying conditions are required, the performance of organic hydrogen-containing molecules is not sufficient for variable signal strength.

发明内容Contents of the invention

针对已公开技术存在的缺陷,本发明的目的是:(1)提供一种可控弛豫时间的复合材料的制备方法;(2)提供该种复合材料的应用;以实现对负载在高分子材料中有机含氢分子造影剂弛豫时间的控制,进而满足高分子材料的MRI造影需求。For the defects of the disclosed technology, the purpose of the present invention is to: (1) provide a preparation method of a composite material with controllable relaxation time; (2) provide the application of this kind of composite material; The control of the relaxation time of the organic hydrogen-containing molecular contrast agent in the material can meet the MRI contrast requirements of polymer materials.

本发明控制有机含氢分子弛豫时间的方法与原理如下:The method and principle of the present invention to control the relaxation time of organic hydrogen-containing molecules are as follows:

物质的弛豫时间主要是由其分子结构和物质状态(如固、液、气)决定的。但分子所处的环境也会影响其弛豫时间,例如,处在不同孔隙尺寸中的水分子,由于受限于孔道壁,弛豫时间会发生变化,因此可以利用水分子的弛豫时间来测量孔道尺寸。那么类似的,也可以通过构建具有孔道结构的高分子基体,对受限于高分子孔道内部的有机含氢分子造影剂的弛豫时间进行控制。有机含氢分子造影剂中含有大量氢原子,当它们受限在高分子形成的孔道中时,分子在运动中会与高分子孔道壁发生碰撞,使得氢原子的弛豫时间变短,进而改变其MRI信号。The relaxation time of a substance is mainly determined by its molecular structure and state of matter (such as solid, liquid, gas). However, the environment of the molecule will also affect its relaxation time. For example, the relaxation time of water molecules in different pore sizes will change due to being limited by the pore wall. Therefore, the relaxation time of water molecules can be used to determine Measure the hole size. Similarly, by constructing a polymer matrix with a pore structure, the relaxation time of the organic hydrogen-containing molecular contrast agent confined inside the polymer pore can be controlled. Organic hydrogen-containing molecular contrast agents contain a large number of hydrogen atoms. When they are confined in the pores formed by polymers, the molecules will collide with the walls of the polymer pores during motion, shortening the relaxation time of the hydrogen atoms, thereby changing the Its MRI signal.

本发明目的通过以下具体技术方案实现:The object of the invention is achieved through the following specific technical solutions:

一种可控弛豫时间的复合材料的制备方法,包括如下步骤:A method for preparing a composite material with controllable relaxation time, comprising the steps of:

(S1)配制纺丝溶液:将高分子材料溶解在溶剂中形成高分子溶液,将有机含氢分子造影剂溶解在溶剂中形成造影剂溶液;(S1) preparing spinning solution: dissolving the polymer material in a solvent to form a polymer solution, and dissolving an organic hydrogen-containing molecular contrast agent in a solvent to form a contrast agent solution;

(S2)将两种溶液混合进行静电纺丝;(S2) mixing the two solutions for electrospinning;

(S3)将收集到的复合纤维产物干燥,浸没在水中,排尽纤维内的空气,得到可控弛豫时间的复合材料。(S3) drying the collected composite fiber product, immersing it in water, exhausting the air in the fiber, and obtaining a composite material with a controllable relaxation time.

步骤(S1)中所述的高分子材料为聚酯类高分子及其衍生物、聚烯烃类高分子及其衍生物、聚酰胺类高分子及其衍生物、淀粉及其衍生物、纤维素及其衍生物、壳聚糖、聚甲醛、透明质酸、纤维蛋白、丝素蛋白,以上聚合物的共混共聚物与嵌段共聚物中的一种或两种以上的混合。The polymer material described in step (S1) is polyester polymer and its derivatives, polyolefin polymer and its derivatives, polyamide polymer and its derivatives, starch and its derivatives, cellulose And its derivatives, chitosan, polyoxymethylene, hyaluronic acid, fibrin, silk fibroin, one or more than two kinds of blended copolymers and block copolymers of the above polymers are mixed.

优选地,聚酯类高分子及其衍生物为聚乙交酯、聚乳酸、聚己内酯、聚羟基乙酸、聚甲基丙烯酸甲酯、聚对苯二甲酸乙二酯、聚对苯二甲酸丁二酯、聚碳酸酯中的至少一种;聚烯烃类高分子及其衍生物为聚乙烯、聚丙烯、聚氯乙烯、聚四氟乙烯、聚异戊二烯、聚乙烯基吡咯烷酮、聚乙烯醇、聚丙烯腈中的至少一种;聚酰胺类高分子及其衍生物为尼龙6、尼龙66、尼龙610、尼龙1212中的至少一种;淀粉及其衍生物为羟乙基淀粉和/或羧甲基淀粉;纤维素及其衍生物为醋酸纤维素、甲基纤维素、乙基纤维素、羟乙基纤维素、氰乙基纤维素、羟丙基纤维素、羟丙基甲基纤维素中的至少一种;共混共聚物与嵌段共聚物为左旋-右旋聚乳酸共聚物、聚乙二醇-聚乳酸嵌段共聚物、聚乙二醇-聚己内酯嵌段共聚物、聚乙二醇-聚乙烯吡咯烷酮嵌段共聚物、聚苯乙烯-聚丁二烯嵌段共聚物、苯乙烯-丁二烯-苯乙烯三嵌段共聚物、聚苯乙烯-聚(乙烯-丁烯)-聚苯乙烯嵌段共聚物、苯乙烯-异戊二烯/丁二烯-苯乙烯嵌段共聚物、聚苯乙烯-聚丁二烯-聚苯乙烯嵌段共聚物中的至少一种。Preferably, the polyester polymer and its derivatives are polyglycolide, polylactic acid, polycaprolactone, polyglycolic acid, polymethyl methacrylate, polyethylene terephthalate, polyethylene terephthalate At least one of butylene formate and polycarbonate; polyolefin polymers and their derivatives are polyethylene, polypropylene, polyvinyl chloride, polytetrafluoroethylene, polyisoprene, polyvinylpyrrolidone, At least one of polyvinyl alcohol and polyacrylonitrile; polyamide polymer and its derivatives are at least one of nylon 6, nylon 66, nylon 610, and nylon 1212; starch and its derivatives are hydroxyethyl starch and/or carboxymethyl starch; cellulose and its derivatives are cellulose acetate, methyl cellulose, ethyl cellulose, hydroxyethyl cellulose, cyanoethyl cellulose, hydroxypropyl cellulose, hydroxypropyl At least one of methyl cellulose; blended copolymers and block copolymers are L-D-polylactic acid copolymers, polyethylene glycol-polylactic acid block copolymers, polyethylene glycol-polycaprolactone Block copolymer, polyethylene glycol-polyvinylpyrrolidone block copolymer, polystyrene-polybutadiene block copolymer, styrene-butadiene-styrene triblock copolymer, polystyrene- Poly(ethylene-butylene)-polystyrene block copolymer, styrene-isoprene/butadiene-styrene block copolymer, polystyrene-polybutadiene-polystyrene block copolymer at least one of the

步骤(S1)中所述的有机含氢分子造影剂为长链脂肪一元酸、长链脂肪一元醇、一元酸一元醇长链脂肪酯、一元酸多元醇长链脂肪酯中的一种或两种以上的混合。The organic hydrogen-containing molecular contrast agent described in the step (S1) is one or both of long-chain fatty monobasic acid, long-chain fatty monohydric alcohol, monobasic acid monohydric alcohol long-chain fatty ester, and monobasic acid polyhydric alcohol long-chain fatty ester. A mixture of the above.

优选地,长链脂肪一元酸为含碳数在8~24的脂肪一元酸;长链脂肪一元醇为含碳数在8~16的脂肪一元醇;一元酸一元醇长链脂肪酯为由长链脂肪一元酸与长链脂肪一元醇形成的含碳数在8~28的酯;一元酸多元醇长链脂肪酯为由丙三醇、蔗糖、葡萄糖、果糖与含碳数在8~18的长链脂肪一元酸形成的酯化合物。Preferably, the long-chain fatty monobasic acid is a fatty monobasic acid with a carbon number of 8 to 24; the long-chain fatty monohydric alcohol is a fatty monohydric alcohol with a carbon number of 8 to 16; The ester of chain fatty monobasic acid and long-chain fatty monohydric alcohol with 8 to 28 carbons; the monobasic acid polyalcohol long-chain fatty ester is composed of glycerol, sucrose, glucose, fructose and the ester with 8 to 18 carbons Esters of long-chain fatty monobasic acids.

更优选地,含碳数在8~24的脂肪一元酸为正辛酸、正壬酸、正癸酸、正十一碳酸、正十二碳酸、异辛酸、异壬酸、异癸酸、异十一碳酸、异十二碳酸、肉豆蔻酸、棕榈酸、硬脂酸、油酸、异油酸、顺芥子酸、神经酸中的至少一种;含碳数在8~16的脂肪一元醇为正辛醇、正壬醇、正癸醇、正十一醇、正十二醇、正十三醇、正十四醇、正十五醇、正十六醇、异辛醇、异壬醇、异癸醇、异十一醇、异十二醇、异十三醇、异十四醇、异十五醇中的至少一种;含碳数在8~28的一元酸一元醇长链脂肪酯为辛酸辛酯、壬酸壬酯、癸酸癸酯、十一碳酸十一酯、十二碳酸十二酯、十三碳酸十三酯、十四碳酸十四酯、癸酸甲酯、癸酸乙酯、癸酸丙酯、癸酸丁酯、癸酸戊酯、癸酸己酯、癸酸庚酯、癸酸辛酯、癸酸壬酯、十二碳酸甲酯、十二碳酸乙酯、十二碳酸丙酯、十二碳酸丁酯、十二碳酸戊酯、十二碳酸己酯、十二碳酸庚酯、十二碳酸辛酯、十二碳酸壬酯、十二碳酸癸酯、十二碳酸十一酯中的至少一种。由丙三醇、蔗糖、葡萄糖、果糖与含碳数在8~18的长链脂肪一元酸形成的酯化合物为单/双/三辛酸甘油酯、单/双/三癸酸甘油酯、单/双/三月桂酸甘油酯、单/双/三硬脂酸甘油酯、单/双/三棕榈酸甘油酯、蔗糖/葡萄糖/果糖癸酸酯、蔗糖/葡萄糖/果糖月桂酸酯、蔗糖/葡萄糖/果糖硬脂酸酯中的至少一种。More preferably, the fatty monobasic acid containing 8 to 24 carbons is n-octanoic acid, n-nonanoic acid, n-decanoic acid, n-undecanoic acid, n-dodecanoic acid, isooctanoic acid, isononanoic acid, isodecanoic acid, isodecanoic acid At least one of monocarbonic acid, isododecanoic acid, myristic acid, palmitic acid, stearic acid, oleic acid, vaccinic acid, cisapinic acid, and nervonic acid; fatty monohydric alcohols containing 8 to 16 carbons are n-octanol, n-nonanol, n-decyl alcohol, n-undecyl alcohol, n-dodecyl alcohol, n-tridecyl alcohol, n-tetradecyl alcohol, n-pentadecanol, n-hexadecanol, isooctyl alcohol, isononyl alcohol, At least one of isodecyl alcohol, isoundecanol, isododecanol, isotridecanol, isotetradecyl alcohol, and isopentadecyl alcohol; monobasic acid monoalcohol long-chain fatty esters containing 8 to 28 carbons Octyl octanoate, nonyl nonanoate, decyl caprate, undecyl undecyl carbonate, dodecyl dodecyl carbonate, tridecyl tridecyl carbonate, tetradecyl tetradecanoate, methyl caprate, capric acid Ethyl caprate, propyl caprate, butyl caprate, pentyl caprate, hexyl caprate, heptyl caprate, octyl caprate, nonyl caprate, methyl dodecanoate, ethyl dodecanoate, Propyl Dicarbonate, Butyl Dodecyl Carbonate, Pentyl Dodecyl Carbonate, Hexyl Dodecyl Carbonate, Heptyl Dodecyl Carbonate, Octyl Dodecyl Carbonate, Nonyl Dodecyl Carbonate, Decyl Dodecyl Carbonate, Dodecyl Carbonate At least one of undecyl esters. The ester compounds formed by glycerol, sucrose, glucose, fructose and long-chain fatty monobasic acids with carbon numbers from 8 to 18 are mono/di/tricaprylic glycerides, mono/di/tricapric glycerides, mono/dicaprylic acid glycerides, Glyceryl Di/Trilaurate, Glyceryl Mono/Dis/Tripostearate, Glyceryl Mono/Di/Tripalmitate, Sucrose/Glucose/Fructose Caprate, Sucrose/Glucose/Fructose Laurate, Sucrose/Glucose /at least one of fructose stearate.

步骤(S1)中所述的溶剂为溶剂戊烷、正己烷、甲基环己烷、二氯甲烷、三氯甲烷、二氯乙烷、四氯乙烷、四氯化碳、丙烯酸甲酯、四氢呋喃、甲基四氢呋喃、N,N-二甲基甲酰胺、N,N-二甲基乙酰胺、二甲基亚砜、乙醚、石油醚、丙酮、甲酸、乙酸、三氟乙酸、六氟异丙醇、二甲苯、甲苯、苯酚、氯苯、硝基苯、甲酚、苯甲醚、甲醇、乙醇、1-丙醇、2-丙醇、1-丁醇、2-丁醇、戊醇中的一种或两种以上的混合。The solvent described in step (S1) is solvent pentane, n-hexane, methylcyclohexane, methylene dichloride, chloroform, ethylene dichloride, tetrachloroethane, carbon tetrachloride, methyl acrylate, Tetrahydrofuran, methyl tetrahydrofuran, N,N-dimethylformamide, N,N-dimethylacetamide, dimethyl sulfoxide, diethyl ether, petroleum ether, acetone, formic acid, acetic acid, trifluoroacetic acid, hexafluoroiso Propanol, xylene, toluene, phenol, chlorobenzene, nitrobenzene, cresol, anisole, methanol, ethanol, 1-propanol, 2-propanol, 1-butanol, 2-butanol, pentanol one or a mixture of two or more.

步骤(S1)中所述的高分子溶液的浓度为5~45wt%,造影剂溶液浓度为20~90wt%。The concentration of the polymer solution in step (S1) is 5-45 wt%, and the concentration of the contrast agent solution is 20-90 wt%.

步骤(S2)中所述静电纺丝条件为:供液装置供液速率0.1~10mL/h,喷丝头与收集装置间距离5~50cm,喷丝头处接高压10~50kV,收集装置处接高压0~-50kV。The electrospinning conditions described in step (S2) are: the liquid supply rate of the liquid supply device is 0.1-10mL/h, the distance between the spinneret and the collection device is 5-50cm, the spinneret is connected to a high voltage of 10-50kV, and the collection device is connected to a high voltage of 10-50kV. Connect to high voltage 0~-50kV.

步骤(S3)中所述的排尽纤维内空气的原因在于,空气与高分子复合纤维的磁导率有显著差别,会影响磁场的不均性,导致MRI成像效果变差,因此不能有空气残留。The reason for exhausting the air in the fiber described in step (S3) is that the magnetic permeability of the air and the polymer composite fiber is significantly different, which will affect the inhomogeneity of the magnetic field and cause the MRI imaging effect to deteriorate, so there cannot be air residual.

步骤(S3)中所述的最终复合纤维产物,有机含氢分子造影剂在复合纤维中的弛豫时间可以最多降低至其本体的10%,且连续变化。In the final composite fiber product described in step (S3), the relaxation time of the organic hydrogen-containing molecular contrast agent in the composite fiber can be reduced to 10% of its bulk at most, and can be changed continuously.

一种复合纤维通过上述方法制备得到。通过以上工艺制备得到的复合纤维可以应用于:(1)为高分子材料提供MRI信号;(2)提供具有标准弛豫时间的样品,用于设备校准;(3)作为具有标准MRI信号强度的植入材料,用于人体内MRI信号标定。A composite fiber is prepared by the above method. The composite fibers prepared by the above process can be applied to: (1) provide MRI signals for polymer materials; (2) provide samples with standard relaxation times for equipment calibration; (3) serve as samples with standard MRI signal strengths The implant material is used for MRI signal calibration in the human body.

本发明的制备方法及所得产物相较于已公开技术具有如下优点及有益效果:Compared with the disclosed technology, the preparation method and the resulting product of the present invention have the following advantages and beneficial effects:

(1)已公开技术均使用含金属的造影剂(螯合物、纳米粒子等)来改变氢原子的弛豫时间,但这些物质都具有一定的毒性或致敏性,本发明方法仅通过改变高分子的结构即可调控氢原子的弛豫时间,未引入其它物质,有更高的安全性;(1) The disclosed technologies all use metal-containing contrast agents (chelates, nanoparticles, etc.) to change the relaxation time of hydrogen atoms, but these substances have certain toxicity or sensitization, and the method of the present invention only changes The structure of the polymer can regulate the relaxation time of the hydrogen atom, and no other substances are introduced, which has higher safety;

(2)本发明方法采用的静电纺丝设备简单,制备具有特定孔洞结构的高分子纤维不影响纤维的完整形貌。因此,本发明的方法不会限制高分子材料原本的应用方向;(2) The electrospinning equipment adopted in the method of the present invention is simple, and the preparation of the polymer fiber with a specific pore structure does not affect the complete shape of the fiber. Therefore, the method of the present invention will not limit the original application direction of polymer materials;

(3)本发明控制弛豫时间的方法适用范围广,可调控的有机含氢分子造影剂种类多,可用于调控含长脂肪链分子中的氢原子的弛豫时间。(3) The method for controlling the relaxation time of the present invention has a wide range of applications, and there are many types of adjustable organic hydrogen-containing molecular contrast agents, which can be used to regulate the relaxation time of hydrogen atoms in molecules containing long aliphatic chains.

附图说明Description of drawings

图1.复合纤维的高分子孔洞结构;Figure 1. The polymer pore structure of the composite fiber;

图2.静电纺丝装置示意图;Figure 2. Schematic diagram of the electrospinning device;

图3.实施例1-4产物、聚丁二酸丁二醇酯与月桂酸的低场核磁共振谱仪测试结果;Fig. 3. the low-field nuclear magnetic resonance spectrometer test result of embodiment 1-4 product, polybutylene succinate and lauric acid;

图4.实施例1-4产物中负载的月桂酸相较于月桂酸本体的相对结晶度;Fig. 4. the relative crystallinity of the lauric acid loaded in the embodiment 1-4 product compared to the lauric acid bulk;

图5.实施例5-8产物、聚对苯二甲酸乙二醇酯与癸酸的低场核磁共振谱仪测试结果。Fig. 5. the low-field nuclear magnetic resonance spectrometer test result of embodiment 5-8 product, polyethylene terephthalate and capric acid.

具体实施方式Detailed ways

下面结合实施例及附图对本发明作进一步详细的描述,但本发明的实施方式不限于此。The present invention will be further described in detail below in conjunction with the embodiments and the accompanying drawings, but the embodiments of the present invention are not limited thereto.

实施例1Example 1

将聚丁二酸丁二醇酯溶解在三氯甲烷中,形成质量分数为60%的A溶液,将月桂酸(十二烷酸)溶解在三氯甲烷中形成质量分数为75%的B溶液,将A、B两种溶液以1:2的质量比混合得到纺丝溶液。Polybutylene succinate is dissolved in chloroform to form a solution A with a mass fraction of 60%, and lauric acid (dodecanoic acid) is dissolved in chloroform to form a solution B with a mass fraction of 75%. , Mix the two solutions of A and B at a mass ratio of 1:2 to obtain a spinning solution.

将溶液通过以下参数进行静电纺丝,供液装置供液速率1mL/h,喷丝头与收集装置间距离20cm,喷丝头处接高压20kV,收集装置处接高压-2kV。The solution was electrospun with the following parameters, the liquid supply rate of the liquid supply device was 1mL/h, the distance between the spinneret and the collection device was 20cm, the spinneret was connected to a high voltage of 20kV, and the collection device was connected to a high voltage of -2kV.

将收集到的复合纤维产物干燥,浸没在水中,排尽纤维内的空气。The collected composite fiber product is dried, immersed in water, and the air in the fiber is exhausted.

实施例2Example 2

将聚丁二酸丁二醇酯溶解在三甲烷中,形成质量分数为40%的A溶液,将月桂酸(十二烷酸)溶解在三氯甲烷中形成质量分数为80%的B溶液,将A、B两种溶液以1:1的质量比混合得到纺丝溶液。Polybutylene succinate is dissolved in trimethane to form a mass fraction of 40% A solution, and lauric acid (dodecanoic acid) is dissolved in trichloromethane to form a mass fraction of 80% B solution, Mix the two solutions of A and B at a mass ratio of 1:1 to obtain a spinning solution.

将溶液通过以下参数进行静电纺丝,供液装置供液速率1mL/h,喷丝头与收集装置间距离20cm,喷丝头处接高压20kV,收集装置处接高压-2kV。The solution was electrospun with the following parameters, the liquid supply rate of the liquid supply device was 1mL/h, the distance between the spinneret and the collection device was 20cm, the spinneret was connected to a high voltage of 20kV, and the collection device was connected to a high voltage of -2kV.

将收集到的复合纤维产物干燥,浸没在水中,排尽纤维内的空气。The collected composite fiber product is dried, immersed in water, and the air in the fiber is exhausted.

实施例3Example 3

将聚丁二酸丁二醇酯溶解在三甲烷中,形成质量分数为40%的A溶液,将月桂酸(十二烷酸)溶解在三氯甲烷中形成质量分数为60%的B溶液,将A、B两种溶液以1:1的质量比混合得到纺丝溶液。Polybutylene succinate is dissolved in trimethane to form the A solution that the mass fraction is 40%, and lauric acid (dodecanoic acid) is dissolved in the trichloromethane to form the B solution that the mass fraction is 60%, Mix the two solutions of A and B at a mass ratio of 1:1 to obtain a spinning solution.

将溶液通过以下参数进行静电纺丝,供液装置供液速率1mL/h,喷丝头与收集装置间距离20cm,喷丝头处接高压20kV,收集装置处接高压-2kV。The solution was electrospun with the following parameters, the liquid supply rate of the liquid supply device was 1mL/h, the distance between the spinneret and the collection device was 20cm, the spinneret was connected to a high voltage of 20kV, and the collection device was connected to a high voltage of -2kV.

将收集到的复合纤维产物干燥,浸没在水中,排尽纤维内的空气。The collected composite fiber product is dried, immersed in water, and the air in the fiber is exhausted.

实施例4Example 4

将聚丁二酸丁二醇酯溶解在三甲烷中,形成质量分数为40%的A溶液,将月桂酸(十二烷酸)溶解在三氯甲烷中形成质量分数为40%的B溶液,将A、B两种溶液以1:1的质量比混合得到纺丝溶液。Polybutylene succinate is dissolved in trimethane to form a mass fraction of 40% A solution, and lauric acid (dodecanoic acid) is dissolved in trichloromethane to form a mass fraction of 40% B solution, Mix the two solutions of A and B at a mass ratio of 1:1 to obtain a spinning solution.

将溶液通过以下参数进行静电纺丝,供液装置供液速率1mL/h,喷丝头与收集装置间距离20cm,喷丝头处接高压20kV,收集装置处接高压-2kV。The solution was electrospun with the following parameters, the liquid supply rate of the liquid supply device was 1mL/h, the distance between the spinneret and the collection device was 20cm, the spinneret was connected to a high voltage of 20kV, and the collection device was connected to a high voltage of -2kV.

将收集到的复合纤维产物干燥,浸没在水中,排尽纤维内的空气。The collected composite fiber product is dried, immersed in water, and the air in the fiber is exhausted.

为说明本发明方法与工艺的有效性,通过低场核磁共振谱仪测定实施例1-4产物的T2弛豫时间,结果如图3所示。通过图3可以得出以下结论:(a)聚丁二酸丁二醇酯的弛豫时间不在测试范围内,所有信息全部来自于月桂酸;(b)月桂酸中所含有的氢原子,表现出2个主要的弛豫时间,第一个在535ms处,第二个在283ms处;(c)月桂酸负载于聚丁二酸丁二醇酯纤维的孔洞中时,其所含氢原子弛豫时间的峰形不变,但在不同加工工艺下,弛豫时间连续可调。说明月桂酸负载于聚丁二酸丁二醇酯纤维中并不改变月桂酸所含氢原子的类型与相对数量,但会有效降低其所含氢原子的弛豫时间。In order to illustrate the effectiveness of the method and process of the present invention, the T2 relaxation time of the products of Examples 1-4 was measured by a low-field nuclear magnetic resonance spectrometer, and the results are shown in FIG. 3 . The following conclusions can be drawn by Fig. 3: (a) the relaxation time of polybutylene succinate is not within the test range, and all information comes from lauric acid; (b) the hydrogen atoms contained in lauric acid show There are two main relaxation times, the first one is at 535ms and the second one is at 283ms; (c) when lauric acid is loaded in the pores of polybutylene succinate fiber, the hydrogen atoms contained in it relax The peak shape of the relaxation time remains unchanged, but the relaxation time is continuously adjustable under different processing techniques. It shows that the loading of lauric acid in polybutylene succinate fiber does not change the type and relative quantity of hydrogen atoms contained in lauric acid, but it will effectively reduce the relaxation time of hydrogen atoms contained in it.

为说明月桂酸在聚丁二酸丁二醇酯中的受限情况,通过差式扫描量热仪测定实施例1-4产物复合纤维中的月桂酸对其本体的相对结晶度,结果如图4所示。从图4中可以看到,由于是相对于月桂酸本体的相对结晶度,因此月桂酸的数值为100%,而实施例1-4中的产物,其中负载的月桂酸相对结晶度均小于100%,且实施例4产物的下降幅度最大。在受限空间中材料的结晶难度增加,结晶度下降已经得到大量研究证实(见Lipeng Han etal.IOP Conference Series:Materials Science and Engineering,2017,182,012010)。从相对结晶度结果可知,实施例4在实施例1-4中,表现出的受限程度最高,对应地实施例4产物中的月桂酸,相较于月桂酸本体弛豫时间下降幅度也最大。In order to illustrate the limited situation of lauric acid in polybutylene succinate, the relative crystallinity of lauric acid in the composite fiber of the product of Example 1-4 is measured by differential scanning calorimeter to its body, and the results are as shown in Fig. 4. As can be seen from Fig. 4, owing to be relative to the relative crystallinity of lauric acid body, so the numerical value of lauric acid is 100%, and the product in embodiment 1-4, wherein the relative crystallinity of lauric acid of loading is all less than 100% %, and the range of decline of the product of Example 4 is the largest. The crystallization difficulty of materials in confined spaces increases, and the decrease in crystallinity has been confirmed by a large number of studies (see Lipeng Han et al. IOP Conference Series: Materials Science and Engineering, 2017, 182, 012010). From the results of relative crystallinity, it can be seen that Example 4 has the highest degree of restriction among Examples 1-4, and correspondingly, the relaxation time of lauric acid in the product of Example 4 has the largest decrease compared with the bulk relaxation time of lauric acid .

实施例5Example 5

将聚对苯二甲酸乙二醇酯溶解在二氯甲烷:三氟乙酸=2:1(质量比)的混合溶液中,形成质量分数为45%的A溶液,将癸酸(十烷酸)溶解在四氢呋喃中形成质量分数为75%的B溶液,将A、B两种溶液以1:2的质量比混合得到纺丝溶液。Polyethylene terephthalate is dissolved in the mixed solution of dichloromethane:trifluoroacetic acid=2:1 (mass ratio) to form A solution with a mass fraction of 45%, and decanoic acid (decanoic acid) Dissolve in tetrahydrofuran to form B solution with a mass fraction of 75%, and mix A and B solutions at a mass ratio of 1:2 to obtain a spinning solution.

将溶液通过以下参数进行静电纺丝,供液装置供液速率0.5mL/h,喷丝头与收集装置间距离15cm,喷丝头处接高压16kV,收集装置处接高压-4kV。The solution was electrospun with the following parameters, the liquid supply rate of the liquid supply device was 0.5mL/h, the distance between the spinneret and the collection device was 15cm, the spinneret was connected to a high voltage of 16kV, and the collection device was connected to a high voltage of -4kV.

将收集到的复合纤维产物干燥,浸没在水中,排尽纤维内的空气。The collected composite fiber product is dried, immersed in water, and the air in the fiber is exhausted.

实施例6Example 6

将聚对苯二甲酸乙二醇酯溶解在二氯甲烷:三氟乙酸=2:1(质量比)的混合溶液中,形成质量分数为30%的A溶液,将癸酸(十烷酸)溶解在四氢呋喃中形成质量分数为80%的B溶液,将A、B两种溶液以1:1的质量比混合得到纺丝溶液。Polyethylene terephthalate is dissolved in the mixed solution of dichloromethane:trifluoroacetic acid=2:1 (mass ratio) to form A solution with a mass fraction of 30%, and decanoic acid (decanoic acid) Dissolve in tetrahydrofuran to form a solution B with a mass fraction of 80%, and mix the two solutions A and B at a mass ratio of 1:1 to obtain a spinning solution.

将溶液通过以下参数进行静电纺丝,供液装置供液速率0.5mL/h,喷丝头与收集装置间距离15cm,喷丝头处接高压16kV,收集装置处接高压-4kV。The solution was electrospun with the following parameters, the liquid supply rate of the liquid supply device was 0.5mL/h, the distance between the spinneret and the collection device was 15cm, the spinneret was connected to a high voltage of 16kV, and the collection device was connected to a high voltage of -4kV.

将收集到的复合纤维产物干燥,浸没在水中,排尽纤维内的空气。The collected composite fiber product is dried, immersed in water, and the air in the fiber is exhausted.

实施例7Example 7

将聚对苯二甲酸乙二醇酯溶解在二氯甲烷:三氟乙酸=2:1(质量比)的混合溶液中,形成质量分数为30%的A溶液,将癸酸(十烷酸)溶解在四氢呋喃中形成质量分数为60%的B溶液,将A、B两种溶液以1:1的质量比混合得到纺丝溶液。Polyethylene terephthalate is dissolved in the mixed solution of dichloromethane:trifluoroacetic acid=2:1 (mass ratio) to form A solution with a mass fraction of 30%, and decanoic acid (decanoic acid) Dissolve in tetrahydrofuran to form a B solution with a mass fraction of 60%, and mix the two solutions A and B at a mass ratio of 1:1 to obtain a spinning solution.

将溶液通过以下参数进行静电纺丝,供液装置供液速率0.5mL/h,喷丝头与收集装置间距离15cm,喷丝头处接高压16kV,收集装置处接高压-4kV。The solution was electrospun with the following parameters, the liquid supply rate of the liquid supply device was 0.5mL/h, the distance between the spinneret and the collection device was 15cm, the spinneret was connected to a high voltage of 16kV, and the collection device was connected to a high voltage of -4kV.

将收集到的复合纤维产物干燥,浸没在水中,排尽纤维内的空气。The collected composite fiber product is dried, immersed in water, and the air in the fiber is exhausted.

实施例8Example 8

将聚对苯二甲酸乙二醇酯溶解在二氯甲烷:三氟乙酸=2:1(质量比)的混合溶液中,形成质量分数为30%的A溶液,将癸酸(十烷酸)溶解在四氢呋喃中形成质量分数为40%的B溶液,将A、B两种溶液以1:1的质量比混合得到纺丝溶液。Polyethylene terephthalate is dissolved in the mixed solution of dichloromethane:trifluoroacetic acid=2:1 (mass ratio) to form A solution with a mass fraction of 30%, and decanoic acid (decanoic acid) Dissolve in tetrahydrofuran to form B solution with a mass fraction of 40%, and mix A and B solutions at a mass ratio of 1:1 to obtain a spinning solution.

将溶液通过以下参数进行静电纺丝,供液装置供液速率0.5mL/h,喷丝头与收集装置间距离15cm,喷丝头处接高压16kV,收集装置处接高压-4kV。The solution was electrospun with the following parameters, the liquid supply rate of the liquid supply device was 0.5mL/h, the distance between the spinneret and the collection device was 15cm, the spinneret was connected to a high voltage of 16kV, and the collection device was connected to a high voltage of -4kV.

将收集到的复合纤维产物干燥,浸没在水中,排尽纤维内的空气。The collected composite fiber product is dried, immersed in water, and the air in the fiber is exhausted.

为说明本发明方法与工艺的普遍适用性,通过低场核磁共振谱仪测定实施例5-8产物的T2弛豫时间,测试结果如图5所示。从图5中可以得到以下结论:(a)聚对苯二甲酸乙二醇酯的弛豫时间不在测试范围内,所有信息全部来自于癸酸;癸酸中所含有的氢原子,表现出2个主要的弛豫时间,第一个在503ms处,第二个在243ms处;与图3结果类似地,负载在聚对苯二甲酸乙二醇酯纤维中的癸酸,其所含氢原子的弛豫时间有效减少了,可实现50ms至150ms的调整。实施例1-4(负载十二烷酸)与实施例5-8(负载十烷酸)的测试结果表明,本发明方法普遍适用于长链脂肪酸/醇/酯中氢原子弛豫时间的调控。In order to illustrate the universal applicability of the method and process of the present invention, the T2 relaxation time of the products of Examples 5-8 was measured by a low-field nuclear magnetic resonance spectrometer, and the test results are shown in FIG. 5 . From Fig. 5, following conclusions can be drawn: (a) the relaxation time of polyethylene terephthalate is not within the test range, and all information comes from capric acid; the hydrogen atom contained in capric acid shows 2 There are three main relaxation times, the first one is at 503ms, the second one is at 243ms; similar to the results in Fig. 3, the capric acid loaded in polyethylene terephthalate fibers contains hydrogen atoms The relaxation time is effectively reduced, which can be adjusted from 50ms to 150ms. The test results of Examples 1-4 (loaded dodecanoic acid) and Examples 5-8 (loaded decanoic acid) show that the method of the present invention is generally applicable to the regulation of hydrogen atom relaxation time in long-chain fatty acids/alcohols/esters .

实施例9Example 9

将聚乙烯醇溶解在水中,形成质量分数为5%的A溶液,将单硬脂酸甘油酯溶解在四氢呋喃中形成质量分数为60%的B溶液,将A、B两种溶液以1:1的质量比混合得到纺丝溶液。Dissolve polyvinyl alcohol in water to form a solution A with a mass fraction of 5%, and dissolve glyceryl monostearate in tetrahydrofuran to form a solution B with a mass fraction of 60%. The two solutions A and B are mixed at a ratio of 1:1 The mass ratio is mixed to obtain a spinning solution.

将溶液通过以下参数进行静电纺丝,供液装置供液速率0.1mL/h,喷丝头与收集装置间距离50cm,喷丝头处接高压50kV,收集装置处接高压-1kV。The solution is electrospun with the following parameters, the liquid supply device supply rate is 0.1mL/h, the distance between the spinneret and the collection device is 50cm, the spinneret is connected to a high voltage of 50kV, and the collection device is connected to a high voltage of -1kV.

将收集到的复合纤维产物干燥,浸没在水中,排尽纤维内的空气。The collected composite fiber product is dried, immersed in water, and the air in the fiber is exhausted.

实施例10Example 10

将苯乙烯-丁二烯-苯乙烯嵌段共聚物溶解在四氢呋喃中,形成质量分数为40%的A溶液,将正十五醇溶解在丙酮中形成质量分数为60%的B溶液,将A、B两种溶液以2:3的质量比混合得到纺丝溶液。Styrene-butadiene-styrene block copolymer is dissolved in tetrahydrofuran to form a solution A with a mass fraction of 40%, and n-pentadecanol is dissolved in acetone to form a solution B with a mass fraction of 60%. The two solutions of B and B are mixed at a mass ratio of 2:3 to obtain a spinning solution.

将溶液通过以下参数进行静电纺丝,供液装置供液速率5mL/h,喷丝头与收集装置间距离30cm,喷丝头处接高压40kV,收集装置处接高压-20kV。The solution was electrospun with the following parameters, the liquid supply rate of the liquid supply device was 5mL/h, the distance between the spinneret and the collection device was 30cm, the spinneret was connected to a high voltage of 40kV, and the collection device was connected to a high voltage of -20kV.

将收集到的复合纤维产物干燥,浸没在水中,排尽纤维内的空气。The collected composite fiber product is dried, immersed in water, and the air in the fiber is exhausted.

实施例11Example 11

将左旋/右旋乳酸无规共聚物溶解在二氯甲烷中,形成质量分数为24%的A溶液,将蔗糖癸酸酯溶解在N,N-二甲基乙酰胺中形成质量分数为90%的B溶液,将A、B两种溶液以1:1的质量比混合得到纺丝溶液。Dissolve L/D-lactic acid random copolymer in dichloromethane to form A solution with a mass fraction of 24%, and dissolve sucrose caprate in N,N-dimethylacetamide to form a mass fraction of 90% The B solution, the two solutions A and B are mixed at a mass ratio of 1:1 to obtain a spinning solution.

将溶液通过以下参数进行静电纺丝,供液装置供液速率5mL/h,喷丝头与收集装置间距离30cm,喷丝头处接高压10kV,收集装置处接高压-50kV。The solution was electrospun with the following parameters, the liquid supply rate of the liquid supply device was 5mL/h, the distance between the spinneret and the collection device was 30cm, the spinneret was connected to a high voltage of 10kV, and the collection device was connected to a high voltage of -50kV.

将收集到的复合纤维产物干燥,浸没在水中,排尽纤维内的空气。The collected composite fiber product is dried, immersed in water, and the air in the fiber is exhausted.

实施例12Example 12

将左旋/右旋乳酸无规共聚物溶解在二氯甲烷中,形成质量分数为24%的A溶液,将蔗糖癸酸酯溶解在N,N-二甲基乙酰胺中形成质量分数为50%的B溶液,将A、B两种溶液以1:1的质量比混合得到纺丝溶液。Dissolve L/D-lactic acid random copolymer in dichloromethane to form A solution with a mass fraction of 24%, and dissolve sucrose caprate in N,N-dimethylacetamide to form a mass fraction of 50% The B solution, the two solutions A and B are mixed at a mass ratio of 1:1 to obtain a spinning solution.

将溶液通过以下参数进行静电纺丝,供液装置供液速率5mL/h,喷丝头与收集装置间距离30cm,喷丝头处接高压10kV,收集装置处接高压-50kV。The solution was electrospun with the following parameters, the liquid supply rate of the liquid supply device was 5mL/h, the distance between the spinneret and the collection device was 30cm, the spinneret was connected to a high voltage of 10kV, and the collection device was connected to a high voltage of -50kV.

将收集到的复合纤维产物干燥,浸没在水中,排尽纤维内的空气。The collected composite fiber product is dried, immersed in water, and the air in the fiber is exhausted.

实施例13Example 13

将醋酸纤维素溶解在N,N-二甲基乙酰胺中,形成质量分数为10%的A溶液,将癸酸癸酯溶解在甲苯中形成质量分数为20%的B溶液,将A、B两种溶液以3:2的质量比混合得到纺丝溶液。Dissolve cellulose acetate in N,N-dimethylacetamide to form a solution A with a mass fraction of 10%, and dissolve decyl caprate in toluene to form a solution B with a mass fraction of 20%. The two solutions were mixed at a mass ratio of 3:2 to obtain a spinning solution.

将溶液通过以下参数进行静电纺丝,供液装置供液速率10mL/h,喷丝头与收集装置间距离25cm,喷丝头处接高压25kV,收集装置处接高压-10kV。The solution is electrospun with the following parameters, the liquid supply device supply rate is 10mL/h, the distance between the spinneret and the collection device is 25cm, the spinneret is connected to a high voltage of 25kV, and the collection device is connected to a high voltage of -10kV.

将收集到的复合纤维产物干燥,浸没在水中,排尽纤维内的空气。The collected composite fiber product is dried, immersed in water, and the air in the fiber is exhausted.

Claims (8)

1. The preparation method of the composite material with controllable relaxation time is characterized by comprising the following preparation steps:
(S1) preparing a spinning solution: dissolving a polymer material in a solvent to form a polymer solution, and dissolving an organic hydrogen-containing molecular contrast agent in the solvent to form a contrast agent solution;
(S2) mixing the two solutions for electrostatic spinning;
(S3) drying the collected composite fiber product, immersing the product in water, and exhausting air in the fiber to obtain a composite material with controllable relaxation time;
the organic hydrogen-containing molecular contrast agent in the step (S1) is one or more than two of long-chain fatty monoacid, long-chain fatty monoalcohol, monoacid monoalcohol long-chain fatty ester and monoacid polyalcohol long-chain fatty ester;
the long-chain fatty monoacid is fatty monoacid with carbon number of 8-24; the long-chain fatty monohydric alcohol is fatty monohydric alcohol with carbon number of 8-16; the monoacid monohydric alcohol long-chain fatty ester is an ester with carbon number of 8-28 formed by long-chain fatty monohydric acid and long-chain fatty monohydric alcohol; the monoacid polyol long-chain fatty ester is an ester compound formed by glycerol, sucrose, glucose, fructose and long-chain fatty monoacid with the carbon number of 8-18.
2. A method of preparing a composite material with controlled relaxation time according to claim 1, wherein: the polymer material in the step (S1) is one or more than two of a polyester polymer and a derivative thereof, a polyolefin polymer and a derivative thereof, a polyamide polymer and a derivative thereof, cellulose and a derivative thereof, chitosan, polyoxymethylene, hyaluronic acid, fibrin, silk fibroin, a blend copolymer of the above polymers and a block copolymer.
3. A method of preparing a composite material with controlled relaxation time according to claim 2, wherein:
the polyester polymer and the derivative thereof are at least one of polyglycolide, polylactic acid, polycaprolactone, polyglycolic acid, polymethyl methacrylate, polyethylene terephthalate, polybutylene terephthalate and polycarbonate; the polyolefin polymer and the derivative thereof are at least one of polyethylene, polypropylene, polyvinyl chloride, polytetrafluoroethylene, polyisoprene, polyvinylpyrrolidone, polyvinyl alcohol and polyacrylonitrile; the polyamide polymer and the derivative thereof are at least one of nylon 6, nylon 66, nylon 610 and nylon 1212; the cellulose and the derivative thereof are at least one of cellulose acetate, methyl cellulose, ethyl cellulose, hydroxyethyl cellulose, cyanoethyl cellulose, hydroxypropyl cellulose and hydroxypropyl methyl cellulose; the blending copolymer and the block copolymer are at least one of a L-polylactic acid copolymer, a polyethylene glycol-polylactic acid block copolymer, a polyethylene glycol-polycaprolactone block copolymer, a polyethylene glycol-polyvinylpyrrolidone block copolymer, a polystyrene-polybutadiene block copolymer, a styrene-butadiene-styrene triblock copolymer, a polystyrene-poly (ethylene-butylene) -polystyrene block copolymer, a styrene-isoprene/butadiene-styrene block copolymer and a polystyrene-polybutadiene-polystyrene block copolymer.
4. A method of preparing a composite material with controlled relaxation time according to claim 1, wherein:
the solvent in the step (S1) is one or more of pentane, N-hexane, methylcyclohexane, dichloromethane, chloroform, dichloroethane, tetrachloroethane, carbon tetrachloride, methyl acrylate, tetrahydrofuran, methyltetrahydrofuran, N-dimethylformamide, N-dimethylacetamide, dimethyl sulfoxide, diethyl ether, petroleum ether, acetone, formic acid, acetic acid, trifluoroacetic acid, hexafluoroisopropanol, xylene, toluene, phenol, chlorobenzene, nitrobenzene, cresol, anisole, methanol, ethanol, 1-propanol, 2-propanol, 1-butanol, 2-butanol and amyl alcohol.
5. A method of preparing a composite material with controlled relaxation time according to claim 1, wherein: the concentration of the polymer solution in the step (S1) is 5-45%, and the concentration of the contrast agent solution is 20-90%.
6. A method of preparing a composite material with controlled relaxation time according to claim 1, wherein: the electrospinning conditions in the step (S2) are as follows: the liquid supply rate of the liquid supply device is 0.1-10 mL/h, the distance between the spinneret and the collecting device is 5-50 cm, the high voltage is 10-50 kV at the spinneret, and the high voltage is 0-50 kV at the collecting device.
7. A composite material with a controlled relaxation time prepared by the method of any one of claims 1 to 6.
8. The use of a controlled relaxation time composite material according to claim 7, wherein (1) MRI signals are provided to the polymer material; (2) Providing a sample having a standard relaxation time for device calibration; (3) As an implant material with standard MRI signal intensity for MRI signal calibration in humans.
CN202210324742.4A 2022-03-30 2022-03-30 Composite material with controllable relaxation time and preparation method and application thereof Active CN114808179B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202210324742.4A CN114808179B (en) 2022-03-30 2022-03-30 Composite material with controllable relaxation time and preparation method and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202210324742.4A CN114808179B (en) 2022-03-30 2022-03-30 Composite material with controllable relaxation time and preparation method and application thereof

Publications (2)

Publication Number Publication Date
CN114808179A CN114808179A (en) 2022-07-29
CN114808179B true CN114808179B (en) 2023-06-16

Family

ID=82532391

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202210324742.4A Active CN114808179B (en) 2022-03-30 2022-03-30 Composite material with controllable relaxation time and preparation method and application thereof

Country Status (1)

Country Link
CN (1) CN114808179B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116590806B (en) * 2023-04-12 2024-07-19 华南理工大学 Binary fatty acid eutectic composite fiber capable of magnetic resonance imaging and preparation and application thereof

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH668555A5 (en) * 1986-02-17 1989-01-13 Schweizerische Viscose X=ray contrast polyester filament contg. X=ray contrast agent - pref. polyethylene contg. bismuth oxide, prodn. and use, esp. for suture yarn
US5558857A (en) * 1991-06-03 1996-09-24 Nycomed Imaging As Contrast agents
CN104562438A (en) * 2013-10-17 2015-04-29 中国科学院理化技术研究所 Gelatin-based micro-nano fiber membrane material and preparation method and application thereof
CN106943606A (en) * 2017-03-15 2017-07-14 贵州灿石正科信息咨询服务有限公司 A kind of acoustic contrast agent

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH668555A5 (en) * 1986-02-17 1989-01-13 Schweizerische Viscose X=ray contrast polyester filament contg. X=ray contrast agent - pref. polyethylene contg. bismuth oxide, prodn. and use, esp. for suture yarn
US5558857A (en) * 1991-06-03 1996-09-24 Nycomed Imaging As Contrast agents
CN104562438A (en) * 2013-10-17 2015-04-29 中国科学院理化技术研究所 Gelatin-based micro-nano fiber membrane material and preparation method and application thereof
CN106943606A (en) * 2017-03-15 2017-07-14 贵州灿石正科信息咨询服务有限公司 A kind of acoustic contrast agent

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
驰豫时间对电纺射流形成及纳米纤维形貌的影响;漆东岳;刘延波;陈威亚;肖友华;;高分子通报(12);第52-59页 *

Also Published As

Publication number Publication date
CN114808179A (en) 2022-07-29

Similar Documents

Publication Publication Date Title
Uppal et al. Hyaluronic acid nanofiber wound dressing—production, characterization, and in vivo behavior
CN105012991B (en) Antibacterial anti hemorrhagic material with non-woven fibrous fabric structure and preparation method thereof
Liu et al. Novel magnetic silk fibroin scaffolds with delayed degradation for potential long-distance vascular repair
US8460692B2 (en) Alginate-based nanofibers and related scaffolds
Kolan et al. Solvent based 3D printing of biopolymer/bioactive glass composite and hydrogel for tissue engineering applications
Fan et al. Regenerated silk fibroin nanofibrous matrices treated with 75% ethanol vapor for tissue-engineering applications
Chen et al. Synthesis and assessment of sodium alginate-modified silk fibroin microspheres as potential hepatic arterial embolization agent
CN114808179B (en) Composite material with controllable relaxation time and preparation method and application thereof
CN102049066A (en) Magnetic composite material and application thereof in regeneration and repair of bone tissues
CN105339485A (en) Three-dimensional structures for cell or tissue culture
Zhou et al. Axon mimicking hydrophilic hollow polycaprolactone microfibres for diffusion magnetic resonance imaging
CN110755684A (en) Microsphere/nano yarn composite scaffold loaded with exosome and growth factor and preparation method thereof
Moradipour et al. Core-shell nanofibers based on polycaprolactone/polyvinyl alcohol and polycaprolactone/collagen for biomedical applications
Feng et al. Electrospun nanofibers with core–shell structure for treatment of bladder regeneration
Zhou et al. Co-electrospraying of tumour cell mimicking hollow polymeric microspheres for diffusion magnetic resonance imaging
Kennell et al. Fish skin gelatin nanofibrous scaffolds spun using alternating field electrospinning and in-vitro tested with tdTomato mice fibroblasts
CN109999222B (en) Preparation method of nerve conduit material based on polyhydroxyalkanoate/sodium alginate electrospun nanofibers
Narayanan et al. Correlation of the stoichiometries of poly (ε-caprolactone) and α-cyclodextrin pseudorotaxanes with their solution rheology and the molecular orientation, crystallite size, and thermomechanical properties of their nanofibers
Rez et al. Tubular poly (ε-caprolactone)/chitosan nanofibrous scaffold prepared by electrospinning for vascular tissue engineering applications
CN114796531B (en) A non-metallic temperature-responsive magnetic resonance imaging composite material and its preparation method and application
CN106620894B (en) In-vivo implantation material capable of nuclear magnetic resonance imaging and preparation method and application thereof
Nergis et al. The effect of polymer concentration on coaxial electrospinning of PVP/PCL core-sheath nanofibers
CN103469347A (en) Preparation method of aliphatic polyester nanofiber with neutral pH after degradation
Zhou et al. Coaxial electrospun biomimetic copolymer fibres for application in diffusion magnetic resonance imaging
Sivan et al. Materials Today Chemistry

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant